Kaminari Medical has closed a €3.8 million funding round with proceeds to be directed to product development, gathering clinical evidence and market entry for its photoacoustic and ultrasound intravascular imaging system.
The round consists of investments (€2.3 million) from Graduate Entrepreneur, NLC Health Ventures, Libertatis Ergo Holding (Leiden University) and Demcon Investment, and completed by an Innovation Credit of €1.5 million from the Netherlands Enterprise Agency (RVO).
Kaminari Medical’s patented intravascular imaging technology uses photoacoustics and ultrasound to provide real-time qualification of plaque composition, particularly lipid-rich plaques that pose the greatest risk of rupture.
“We are thrilled to be supported by such esteemed investors who share our vision of transforming cardiovascular diagnostics and therapy guidance,” said Jeroen Kodde, CEO of Kaminari Medical. “This funding allows us to expedite the development of our technology, bring it to healthcare providers, and ultimately improve outcomes for millions of patients affected by cardiovascular disease.”
“With this investment we can bring our scientific endeavours to the patient’s bedside: Knowledge valorisation at its finest”, said Ton van der Steen, co-founder of Kaminari Medical and head of the department of Biomedical Engineering of Erasmus Medical Centre.
“We believe Kaminari Medical is uniquely positioned to disrupt the intravascular imaging space with its innovative approach to cardiovascular diagnostics,” said graduate entrepreneur representative Filip Cuypers. “Their novel solution will give physicians the tools they need to make procedures safer, more effective, and ultimately save lives. We are excited to support the company in this next stage of growth.”
“We’re inspired by physicians’ enthusiasm and the growing evidence supporting plaque characterisation for accurate coronary artery disease diagnosis and treatment,” said Alessandro Radaelli, venture partner at NLC Health Ventures and Ram Siddappa, investment manager at LEH, who have been appointed to Kaminari Medical’s supervisory board.
